ATE428407T1 - Oralen arzneiform mit oeffnungen in der äusseren hülle - Google Patents

Oralen arzneiform mit oeffnungen in der äusseren hülle

Info

Publication number
ATE428407T1
ATE428407T1 AT05077703T AT05077703T ATE428407T1 AT E428407 T1 ATE428407 T1 AT E428407T1 AT 05077703 T AT05077703 T AT 05077703T AT 05077703 T AT05077703 T AT 05077703T AT E428407 T1 ATE428407 T1 AT E428407T1
Authority
AT
Austria
Prior art keywords
openings
core
outer case
oral medicinal
medicinal form
Prior art date
Application number
AT05077703T
Other languages
English (en)
Inventor
Luigi Martini
Chi Leung Li
Philip Smith
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE428407T1 publication Critical patent/ATE428407T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23B—TURNING; BORING
    • B23B37/00—Boring by making use of vibrations of ultrasonic frequency

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT05077703T 2000-11-08 2001-11-02 Oralen arzneiform mit oeffnungen in der äusseren hülle ATE428407T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0027471.2A GB0027471D0 (en) 2000-11-08 2000-11-08 Processes

Publications (1)

Publication Number Publication Date
ATE428407T1 true ATE428407T1 (de) 2009-05-15

Family

ID=9902924

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01993458T ATE314839T1 (de) 2000-11-08 2001-11-02 Prozess zur herstellung einer oralen arzneiform
AT05077703T ATE428407T1 (de) 2000-11-08 2001-11-02 Oralen arzneiform mit oeffnungen in der äusseren hülle

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01993458T ATE314839T1 (de) 2000-11-08 2001-11-02 Prozess zur herstellung einer oralen arzneiform

Country Status (9)

Country Link
US (2) US7923027B2 (de)
EP (2) EP1333813B1 (de)
JP (1) JP4290981B2 (de)
AT (2) ATE314839T1 (de)
AU (1) AU2002218280A1 (de)
DE (2) DE60138428D1 (de)
ES (2) ES2256329T3 (de)
GB (1) GB0027471D0 (de)
WO (1) WO2002038131A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
NZ532096A (en) * 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100995486B1 (ko) * 2002-09-28 2010-11-22 맥네일-피피씨, 인코포레이티드 개구가 있는 쉘을 포함하는 속방성 투여형
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
EP1686967A4 (de) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd Carvedilol-freie base, salze, wasserfreie formen oder solvate davon, entsprechende pharmazeutische zusammensetzungen, formulierungen mit kontrollierter freisetzung und behandlungs- oder abgabeverfahren
US8067029B2 (en) * 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7404708B2 (en) * 2004-12-07 2008-07-29 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
BRPI0520830A2 (pt) * 2005-12-30 2009-05-19 Accu Break Technologies Inc forma de dosagem farmacêutica sólida, método de subdividir uma forma de dosagem farmacêutica sólida, método de administração de uma parte de uma subunidade ativa de uma forma de dosagem farmacêutica sólida, método de administração de um ingrediente farmacêutico ativo que está presente dentro de uma subunidade ativa de uma forma de dosagem farmacêutica sólida e método de produção de uma forma de dosagem farmacêutica sólida
US8273105B2 (en) 2008-02-20 2012-09-25 Tyco Healthcare Group Lp Compound barb medical device and method
BRPI0822655A2 (pt) * 2008-06-04 2015-06-30 Colgate Palmolive Co Implemento e sistema para cuidado oral
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
AU2009270768A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
CN113840595A (zh) 2019-05-17 2021-12-24 葛兰素史密斯克莱知识产权发展有限公司 基质组合物，其包含(S)-5-苄基-N-(5-甲基-4-氧代-2,3,4,5-四氢苯并[b][1,4]氧氮杂环庚三烯-3-基)-4H-1,2,4-三唑-3-甲酰胺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1575050A1 (de) * 1966-01-12 1972-04-13 Misto Gen Equipment Co Ultraschall-Nebelerzeugungsgeraet
US4447235A (en) * 1981-05-07 1984-05-08 John M. Clarke Thoracentesis device
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
EP0303769A3 (de) * 1987-08-18 1989-10-25 Balzers Aktiengesellschaft Vorrichtung zur Übertragung von Drehbewegungen durch die Wand einer Vakuumkammer
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
JPH02124251A (ja) 1988-10-28 1990-05-11 Tanaka Kikinzoku Kogyo Kk 微細穴加工方法
US5123903A (en) * 1989-08-10 1992-06-23 Medical Products Development, Inc. Disposable aspiration sleeve for ultrasonic lipectomy
US5317932A (en) * 1992-02-28 1994-06-07 The Dow Chemical Company Sample probe
US5300046A (en) * 1992-03-30 1994-04-05 Symbiosis Corporation Thoracentesis sheath catheter assembly
US5674235A (en) * 1995-05-10 1997-10-07 Ultralase Technologies International Ultrasonic surgical cutting instrument
JPH1024491A (ja) 1996-07-11 1998-01-27 Seidensha Denshi Kogyo Kk 超音波加工装置
US6783662B2 (en) * 1999-03-18 2004-08-31 Exxonmobil Research And Engineering Company Cavitation enhanced liquid atomization
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AU1444301A (en) * 1999-10-29 2001-05-14 Merck & Co., Inc. Osmotic controlled release drug delivery device
US7708504B2 (en) * 2005-08-29 2010-05-04 Savannah River Nuclear Solutions, Llc Pneumatic conveyance apparatus and process

Also Published As

Publication number Publication date
EP1333813A2 (de) 2003-08-13
ES2323879T3 (es) 2009-07-27
US8765065B2 (en) 2014-07-01
WO2002038131A2 (en) 2002-05-16
EP1655024A1 (de) 2006-05-10
WO2002038131A3 (en) 2002-09-12
ES2256329T3 (es) 2006-07-16
EP1333813B1 (de) 2006-01-04
DE60116530D1 (de) 2006-03-30
US7923027B2 (en) 2011-04-12
US20110131754A1 (en) 2011-06-09
ATE314839T1 (de) 2006-02-15
GB0027471D0 (en) 2000-12-27
US20040062806A1 (en) 2004-04-01
EP1655024B1 (de) 2009-04-15
DE60116530T2 (de) 2006-08-10
JP4290981B2 (ja) 2009-07-08
AU2002218280A1 (en) 2002-05-21
DE60138428D1 (de) 2009-05-28
JP2004512903A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE428407T1 (de) Oralen arzneiform mit oeffnungen in der äusseren hülle
ATE476957T1 (de) Pharmazeutische zusammensetzung auf fondantbasis
CA2433032A1 (en) Sustained release drug delivery devices with coated drug cores
CY1111825T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ενα οπιουχο ανταγωνιστη
SE9102072D0 (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
CA2432203A1 (en) Sustained release drug delivery devices with multiple agents
CA2396152A1 (en) Osmotic device within an osmotic device
DE69831504D1 (de) Orale verabreichungsform enthaltend einen protonenpumpeninhbitor (z.b. pantoprazole)
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
DE69811278D1 (de) Gegen magensaft geschützte omeprazol-mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
WO2002102182A3 (en) Tongue and mouth stud for dispensing a substance
CL2007003010A1 (es) Forma de dosificacion oral que comprende un nucleo erosionable que contiene un principio activo de caracter basico debil, un recubrimiento erosionable en torno a dicho nucleo con una o mas abertura que atraviesn el recubrimiento y conectan al nucleo con el medio de uso; procedimiento de preparacion; y uso (divisional de 260-03).
FI990958A0 (fi) Vuotoindikaattori, menetelmä sen valmistamiseksi ja vuotoindikaattorilla varustettu pakkaus
MXPA03007272A (es) Formulacion de medicamento que contiene agonista muscarinico.
RU2001109481A (ru) Антиангинальное средство
IT1320262B1 (it) Dispositivo erogatore per la somministrazione transdermica di unasostanza contenente un principio attivo e relativa testina erogatrice.
IT1318458B1 (it) Contenitore a ridotto ingombro per camicie e simili.
IT1314515B1 (it) Boccaglio per erogatore.
GC0000031A (en) Inhalation device including an aerosol medicament dispenser.
ES1049958Y (es) Boquilla nebulizadora perfeccionada.
RU2001132451A (ru) Применение устройства для насыщения воздуха лекарственными веществами в качестве устройства для вакцинации
ES1047933Y (es) Irrigador nasal.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties